Turoctocog alfa
Definition: Turoctocog alfa (trade name NovoEight) is a recombinant antihemophilic factor VIII used for the treatment of and prophylaxis of bleeding patients with haemophilia A. It is marketed by Novo Nordisk. source: Wikipedia
- ID
- 735055007
- ID date
- 20 Apr 2018
- Previous ID
- 24608911000001104
- Name
- Turoctocog alfa